Wong J.Y.C. Filippi A.R. Dabaja B.S. et al.

Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).

Int J Radiat Oncol Biol Phys. 101: 521-529

Wong J.Y.C., Filippi A.R., Scorsetti M., et al., Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia, Lancet Oncol, 21 (10), 2020, e477–e487.

Peters Dalle J.H., Locatelli F.,, C. et al.

Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study.

J Clin Oncol. 39: 295-307Davies S.M. Ramsay N.K. Klein J.P. et al.

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

J Clin Oncol. 18: 340-347Bunin N. Aplenc R. Kamani N. et al.

Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.

Bone Marrow Transplant. 32: 543-548Gupta T. Kannan S. Dantkale V. t et al.

Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis, Hematology/Oncology and Stem Cell.

Therapy. 4: 17-29

Saglio F., Zecca M., Pagliara D.,et al., Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective study, Bone Marrow Transplant, 55 (10), 2020, 1918–1927.

Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia.

Curr Oncol Rep. 20: 74

Baker K.S., Leisenring W.M., Goodman P.J., et al., Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation, Blood, 133 (26), 2019, 2790–2799.

Clift R.A. Buckner C.D. Appelbaum F.R. et al.

Allogeneic Marrow Transplantation in Patients With Acute Myeloid Leukemia in First Remission: A Randomized Trial of Two Irradiation Regimens.

Blood. 76: 1867-1871Vogel J. Hui S. Hua C.H. et al.

Pulmonary Toxicity After Total Body Irradiation - Critical Review of the Literature and Recommendations for Toxicity Reporting.

Front Oncol. 11: 708906Esiashvili N. Lu X. Ulin K. et al.

Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children’s Oncology Group.

Int J Radiat Oncol Biol Phys. 104: 513-521

Oertel M., Martel J., Mikesch J.H., et al., The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation, Cancers, 13 (22), 2021, 5640.

Renal toxicity in children undergoing total body irradiation for bone marrow transplant.

Radiother Oncol. 90: 242-246

Sieker K., Fleischmann M., Trommel M., et al., Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies, Strahlenther Onkol, 198 (6), 2022, 547–557.

Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant Relapse.

Front Oncol. 12: 802648Peñagarícano J.A. Chao M. Van Rhee F. et al.

Clinical feasibility of TBI with helical tomotherapy.

Bone Marrow Transplant. 46: 929-935Hui S.K. Kapatoes J. Fowler J. et al.

Feasibility study of helical tomotherapy for total body or total marrow irradiation.

Med Phys. 32: 3214-3224Han C. Liu A. Wong J.Y.C.

Target Coverage and Normal Organ Sparing in Dose-Escalated Total Marrow and Lymphatic Irradiation: A Single-Institution Experience.

Front Oncol. 12: 946725Aydogan B. Mundt A.J. Roeske J.C.

Linac-based intensity modulated total marrow irradiation (IM-TMI).

Technol Cancer Res Treat. 5: 513-519

Total marrow irradiation with RapidArc volumetric arc therapy.

Int J Radiat Oncol Biol Phys. 81: 592-599Schultheiss T.E. Liu A. Wong J., et al.

Total marrow and total lymphatic irradiation with helical tomotherapy.

Med Phys. 31 ()

Schultheiss T.E., Wong J., Liu A., et al., Normal tissue sparing in total marrow and total lymphatic irradiation with helical tomotherapy, Int J Radiat Oncol Biol Phys, 60 (1), 2004, S544–S545.

Image-guided total marrow and total lymphatic irradiation using helical tomotherapy.

Int J Radiat Oncol Biol Phys. 67: 1259-1267

Targeted Total Marrow Irradiation Using Three-Dimensional Image-Guided Tomographic Intensity-Modulated Radiation Therapy: An Alternative to Standard Total Body Irradiation.

Biol Blood Marrow Transplant. 12: 306-315

Radiation-Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens.

Int J Radiat Oncol Biol Phys. 105: 1025-1033

Acute and Late Toxicities with Total Marrow Irradiation.

in: Wong J.Y.C. Hui S.K. Total marrow irradiation: a comprehensive review. Springer International Publishing, Cham: 187-196

Kim J.H., Stein A., Tsai N., et al., Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation, Int J Radiat Oncol Biol Phys, 89 (1), 2014, 75–81.

Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission.

Transplant Cell Ther. 28: 368.e1-368.e7

Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single Center.

Biol Blood Marrow Transplant. 26: 292-299

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.

Biol Blood Marrow Transplant. 23: 618-624

Phase II Study of Dose Escalated Total Marrow and Lymphoid Irradiation (TMLI) in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia.

Int J Radiat Oncol Biol Phys. 108: S155

Ladbury C., Armenian S., Bosworth A., et al., Risk of subsequent malignant neoplasms following hematopoietic stem cell transplantation with total body irradiation or total marrow irradiation: insights from early follow-up, Transplant Cell Ther, 28 (12), 2022, 860.e1-860.e6.

Han C. Liu A. Wong J.Y.C.

Estimation of radiation-induced, organ-specific, secondary solid-tumor occurrence rates with total body irradiation and total marrow irradiation treatments.

Pract Radiat Oncol. 10: e406-e414Kong F. Liu S. Liu L. et al.

Clinical study of total bone marrow combined with total lymphatic irradiation pretreatment based on tomotherapy in hematopoietic stem cell transplantation of acute leukemia.

Front Oncol. 12: 936985

Haraldsson A., Wichert S., Engström P.E., et al., Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantation, Eur J Haematol, 107 (4), 2021, 393–407.

Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience.

Leuk Lymphoma. 61: 2859-2867

TBI lung dose comparisons using bilateral and anteroposterior delivery techniques and tissue density corrections.

J Appl Clin Med Phys. 16: 5293

Dosimetric study and verification of total body irradiation using helical tomotherapy and its comparison to extended SSD technique.

Med Dosim. 35: 243-249

Total Body Irradiation (TBI) using Helical Tomotherapy in children and young adults undergoing stem cell transplantation.

Radiat Oncol. 8: 92

Springer A., Hammer J., Winkler E., et al., Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience, Radiat Oncol, 11 (1), 2016, 46.

Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability.

Radiother Oncol. 129: 527-533

Image-guided volumetric-modulated arc therapy of total body irradiation: An efficient workflow from simulation to delivery.

J Appl Clin Med Phys. 22: 169-177

Kovalchuk N., Simiele E., Skinner L., et al., The Stanford Volumetric Modulated Arc Therapy Total Body Irradiation Technique, Pract Radiat Oncol, 12 (3), 2022, 245–258.

A Step Toward Making VMAT TBI More Prevalent: Automating the Treatment Planning Process.

Pract Radiat Oncol. 11: 415-423

Konishi T., Ogawa H., Najima Y., et al., Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study, J Radiat Res, 61 (6), 2020, 969–976.

Optimized Conformal Total Body Irradiation Among Recipients of TCRαβ/CD19-Depleted Grafts in Pediatric Patients With Hematologic Malignancies: Single-Center Experience.

Front Oncol. 11: 785916

Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes.

Transplant Cell Ther. 28: 113.e1-113.e8

Marquez C., Hui C., Simiele E., et al., Volumetric modulated arc therapy total body irradiation in pediatric and adolescent/young adult patients undergoing stem cell transplantation: Early outcomes and toxicities, Pediatr Blood Cancer, 69 (6), 2022, e29689.

Dose-escalated volumetric modulated arc therapy for total marrow irradiation: A feasibility dosimetric study with 4DCT planning and simultaneous integrated boost.

Phys Med. 78: 123-128

Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant.

Radiother Oncol. 98: 382-386

Haploidentical hematopoietic SCT using helical tomotherapy for total-body irradiation and targeted dose boost in patients with high-risk/refractory acute lymphoblastic leukemia.

Bone Marrow Transplant. 53: 438-448